Traci Turner - Publications, H-index & Citations

Back

Traci Turner

medpace

16H-index

50Paper Count

3.7KCitation Count

Published Papers 18

Publication Date

Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial

The Lancet Diabetes & Endocrinology

IF41.8

2025-12-18

PREAI

Frederick J Raal; Jean Bergeron; Daniel Gaudet; Robert S Rosenson; David R Sullivan; Traci Turner; Robert A Hegele; Christie M Ballantyne; Joshua W Knowles; Nicholas J Leeper; Ira J Goldberg; Rong Zhou; Ma'an Muhsin; Jennifer Hellawell; James Hamilton; Gerald F Watts

Save

Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy

EUROPEAN HEART JOURNAL

IF35.6

2024-06-10

OAAI

Gaudet, Daniel; Greber-Platzer, Susanne; Reeskamp, Laurens F.; Iannuzzo, Gabriella; Rosenson, Robert S.; Saheb, Samir; Stefanutti, Claudia; Stroes, Erik; Wiegman, Albert; Turner, Traci; Ali, Shazia; Banerjee, Poulabi; Drewery, Tiera; McGinniss, Jennifer; Waldron, Alpana; George, Richard T.; Zhao, Xue-Qiao; Pordy, Robert; Zhao, Jian; Bruckert, Eric; Raal, Frederick J.

Save

Response to PCSK9 Inhibition in Homozygous Familial Hypercholesterolemia Patients is Variable in Different Regions of the World and According to Age

CIRCULATION

IF38.6

2023-11-07

PREAI

Raal, Frederick J.; Mehta, Vimal; Kayikcioglu, Meral; Blom, Dirk J.; Gupta, Preeti; Durst, Ronen; Asprusten, Emil A.; Turner, Traci; Bahassi, El Mustapha; Vest, Jeffrey; Caldwell, Kate

Save

Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2022-10-28

OAAI

Martin, Seth S.; Ditmarsch, Marc; Simmons, Mark; Alp, Nicholas; Turner, Traci; Davidson, Michael H.; Kastelein, John J. P.

Save

Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2022-05-03

168

OAAI

Nissen, Steven E.; Wolski, Kathy; Balog, Craig; Swerdlow, Daniel, I; Scrimgeour, Alison C.; Rambaran, Curtis; Wilson, Rosamund J.; Boyce, Malcom; Ray, Kausik K.; Cho, Leslie; Watts, Gerald F.; Koren, Michael; Turner, Traci; Stroes, Erik S.; Melgaard, Carrie; Campion, Giles, V

Save

Cascade Screening for Familial Hypercholesterolemia in South Africa The Wits FIND-FH Program

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2020-11-01

OAAI

Raal, Frederick J.; Bahassi, El Mustapha; Stevens, Belinda; Turner, Traci A.; Stein, Evan A.

Save

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2020-04-16

501

OAAI

Raal, Frederick J.; Kallend, David; Ray, Kausik K.; Turner, Traci; Koenig, Wolfgang; Wright, R. Scott; Wijngaard, Peter L. J.; Curcio, Danielle; Jaros, Mark J.; Leiter, Lawrence A.; Kastelein, John J. P.

Save

CASCADE SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA IN SOUTH AFRICA REVEALS A SIGNIFICANT NUMBER OF SUBJECTS WITH MORE THAN ONE FH MUTATION: THE WITS FIND-FH PROGRAM.

ATHEROSCLEROSIS

IF5.7

2019-08-01

OAAI

Raal, F.; Bahassi, E. M.; Stevens, B.; Turner, T.; Stein, E.

Save

CONFIRMATION OF PATHOGENICITY OF A RARE LOW DENSITY LIPOPROTEIN RECEPTOR MUTATION CAUSING HOMOZYGOUS AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH)

ATHEROSCLEROSIS

IF5.7

2019-08-01

PREAI

Turner, T.; Stein, E.; Bahassi, E. M.

Save

SAFETY, TOLERABILITY AND LDL-C REDUCTION WITH A NOVEL ANTI-PCSK9 RECOMBINANT FUSION PROTEIN (LIB003): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY

ATHEROSCLEROSIS

IF5.7

2019-08-01

PREAI

Stein, E.; Toth, P.; Butcher, M. B.; Kereiakes, D.; Magnu, P.; Bays, H.; Zhou, R.; Turner, T. A.

Save

Response by Kusters et al to Letter Regarding Article, Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)

CIRCULATION

IF38.6

2018-02-06

OAAI

Kusters, D. Meeike; Braamskamp, Marjet J. A. M.; Langslet, Gisle; McCrindle, Brian W.; Cassiman, David; Francis, Gordon A.; Gagne, Claude; Gaudet, Daniel; Morrison, Katherine M.; Wiegman, Albert; Turner, Traci; Miller, Elinor; Raichlen, Joel; Martin, Paul D.; Stein, Evan A.; Kastelein, John J. P.; Hutten, Barbara A.

Save

Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)

CIRCULATION

IF38.6

2017-07-25

OAAI

Braamskamp, Marjet J. A. M.; Langslet, Gisle; McCrindle, Brian W.; Cassiman, David; Francis, Gordon A.; Gagne, Claude; Gaudet, Daniel; Morrison, Katherine M.; Wiegman, Albert; Turner, Traci; Miller, Elinor; Kusters, D. Meeike; Raichlen, Joel S.; Martin, Paul D.; Stein, Evan A.; Kastelein, John J. P.; Hutten, Barbara A.

Save

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2017-04-13

734

OAAI

Ray, Kausik K.; Landmesser, Ulf; Leiter, Lawrence A.; Kallend, David; Dufour, Robert; Karakas, Mahir; Hall, Tim; Troquay, Roland P. T.; Turner, Traci; Visseren, Frank L. J.; Wijngaard, Peter; Wright, R. Scott; Kastelein, John J. P.

Save

Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes

CLINICAL THERAPEUTICS

IF3.6

2015-12-01

PREAI

Turner, Traci; Stein, Evan A.

Save

Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study

JOURNAL OF CLINICAL LIPIDOLOGY

IF4.6

2015-11-01

OAAI

Braamskamp, Marjet J. A. M.; Langslet, Gisle; McCrindle, Brian W.; Cassiman, David; Francis, Gordon A.; Gagne, Claude; Gaudet, Daniel; Morrison, Katherine M.; Wiegman, Albert; Turner, Traci; Kusters, D. Meeike; Miller, Elinor; Raichlen, Joel S.; Wissmar, Jenny; Martin, Paul D.; Stein, Evan A.; Kastelein, John J. P.

Save

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

LANCET

IF88.5

2015-01-01

646

PREAI

Raal, Frederick J.; Stein, Evan A.; Dufour, Robert; Turner, Traci; Civeira, Fernando; Burgess, Lesley; Langslet, Gisle; Scott, Russell; Olsson, Anders G.; Sullivan, David; Hovingh, G. Kees; Cariou, Bertrand; Gouni-Berthold, Ioanna; Somaratne, Ransi; Bridges, Ian; Scott, Rob; Wasserman, Scott M.; Gaudet, Daniel

Save

EFFECT OF ROSUVASTATIN THERAPY ON CAROTID INTIMA MEDIA THICKNESS IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA: FINDINGS FROM THE CHARON STUDY

ATHEROSCLEROSIS

IF5.7

2014-08-01

PREAI

Braamskamp, M. J. A. M.; Langslet, G.; McCrindle, B. W.; Cassiman, D.; Francis, G. A.; Gagne, C.; Gaudet, D.; Morrison, K. M.; Wiegman, A.; Turner, T.; Miller, E.; Raichlen, J. S.; Martin, P. G.; Stein, E. A.; Kastelein, J. J. P.

Save

EFFICACY AND SAFETY OF ROSUVASTATIN IN CHILDREN AGED 6-17 YEARS WITH FAMILIAL HYPERCHOLESTEROLEMIA: FINDINGS FROM THE CHARON STUDY

ATHEROSCLEROSIS

IF5.7

2014-08-01

PREAI

Braamskamp, M.; Langslet, G.; McCrindle, B. W.; Cassiman, D.; Francis, G. A.; Gagne, C.; Gaudet, D.; Morrison, K. M.; Wiegman, A.; Turner, T.; Miller, E.; Raichlen, J. S.; Martin, P. G.; Martin, P. D.; Stein, E. A.; Kastelein, J. J. P.

Save

Research Directions